PX1 Research provides reference-grade Thymosin Alpha 1 for sale, manufactured in domestic GMP-compliant facilities and rigorously tested for laboratory research applications. Every lot of this synthetic 28-amino acid peptide undergoes RP-HPLC and mass spectrometry analysis to guarantee high chemical purity and identity verification, paired with quantitative endotoxin testing for uncompromised in vitro and in vivo assays.
PX1 Research provides reference-grade Thymosin Alpha 1 for sale, manufactured in domestic GMP-compliant facilities and rigorously tested for laboratory research applications. Every lot of this synthetic 28-amino acid peptide undergoes RP-HPLC and mass spectrometry analysis to guarantee high chemical purity and identity verification, paired with quantitative endotoxin testing for uncompromised in vitro and in vivo assays.
Thymosin Alpha 1 (TA1) is an acidic 28-amino acid peptide original isolated from bovine thymus tissue (Thymosin Fraction 5) and subsequently produced via solid-phase peptide synthesis (SPPS) for analytical and experimental evaluation. In cellular biology and immunology, TA1 serves as a foundational reference molecule for investigating immune cell differentiation, cytokine expression, and innate signaling cascades in controlled laboratory settings.
When procurement officers and principal investigators search for thymosin alpha 1 for sale, maintaining strict sequence integrity and batch consistency is paramount. Reference-grade compounds require explicit molecular characterization to ensure that experimental outcomes reflect the exact peptide dynamics under study rather than residual synthetic byproducts or bacterial lipopolysaccharides. Researchers can access fully verified documentation across our entire research peptide catalog to validate sequence fidelity prior to assay integration.
Acquiring research peptides for institutional or academic research requires strict compliance verification. Not all commercial sources supply compounds manufactured to institutional purity baselines. When evaluating options for thymosin alpha 1 for sale, laboratory procurement protocols should audit prospective suppliers against specific technical criteria:
1. Domestic Synthesis & GMP Compliance: Compounds should be synthesized within USA-based, GMP-compliant facilities to ensure rigorous quality control and environmental oversight during peptide assembly. 2. Lot-Specific ISO 17025 Testing: Every batch must be independently verified by an accredited ISO 17025 laboratory using reverse-phase high-performance liquid chromatography (RP-HPLC) and electrospray ionization mass spectrometry (ESI-MS). 3. Quantitative Endotoxin Verification: Lyophilized vials must be subjected to Limulus Amebocyte Lysate (LAL) testing to confirm bacterial endotoxin levels remain strictly under laboratory thresholds (<0.01 EU/μg). 4. Traceable Certificates of Analysis: Every order must include a lot-traceable COA that maps directly to the physical vial provided, complete with raw HPLC chromatograms and mass spectra. 5. Secure Logistics: Immediate dispatch from domestic distribution centers (shipping same-day Monday through Friday from facilities in California and Arizona) ensures chemical stability and mitigates environmental degradation during transit.
Thymosin Alpha 1 exhibits a molecular weight of approximately 3108.3 Da and an amino acid sequence of Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH, featuring an N-terminal acetylation. This specific primary structure governs its secondary folding characteristics, electrostatic charge distribution, and receptor binding dynamics in cell culture models.
In analytical chemistry workflows, verifying the monoisotopic mass and chromatographic retention time of the synthetic sequence confirms structural identity. Investigators ordering our specialized Thymosin Alpha 1 product page receive fully documented analytical profiles establishing sequence fidelity, verifying the complete absence of truncated sequences or misfolded enantiomers that could skew preclinical experimental data.
To contextualize the signaling mechanisms of Thymosin Alpha 1, researchers often evaluate its activity alongside other endogenous or synthetic peptides involved in cellular defense, tissue architecture, and regulatory pathways. A clear comparative framework helps clarify distinct receptor affinities and operational paradigms across various experimental models.
For example, while Thymosin Alpha 1 acts predominantly via Toll-like receptor (TLR) pathways to influence T-cell and dendritic cell maturation, Thymosin Beta-4 operates primarily through actin-monomer sequestering to regulate cell migration and tissue remodeling. Similarly, compounds such as BPC-157 target focal adhesion kinase and angiogenic signaling pathways, whereas the LL-37 antimicrobial peptide functions via direct membrane perturbation and chemokine receptor modulation. Selecting the correct compound within our broader immunomodulatory research peptides selection depends entirely on the specific signaling axis targeted by your experimental protocol.
Preclinical studies suggest that Thymosin Alpha 1 interacts directly with pattern recognition receptors, particularly Toll-like receptor 4 (TLR4) and Toll-like receptor 7 (TLR7), on immature dendritic cells and monocytes. In vitro data indicate that this interaction triggers downstream signaling cascades through MyD88-dependent pathways, ultimately upregulating nuclear factor kappa B (NF-κB) and activating mitogen-activated protein kinase (MAPK) pathways.
In rodent models and primary cell cultures, these signaling cascades lead to elevated expression of major histocompatibility complex (MHC) Class I molecules, increased production of interleukin-2 (IL-2), and enhanced maturation of helper T-cells (Th1 phenotype). Furthermore, laboratory assays demonstrate that TA1 can influence indoleamine 2,3-dioxygenase (IDO) expression, suggesting a nuanced regulatory role in maintaining immune homeostasis under inflammatory stress conditions.
To ensure precise molarity and preserve peptide integrity during downstream experiments, researchers must follow strict aseptic reconstitution procedures. Lyophilized Thymosin Alpha 1 should be equilibrated to room temperature inside a laminar flow hood before reconstitution to prevent condensation accumulation within the vial.
Reconstitution should be performed using sterile, bacteriostatic water or laboratory-grade phosphate-buffered saline (PBS, pH 7.4). Solvents should be directed gently against the glass vial wall rather than directly onto the lyophilized cake, followed by gentle swirling. Pipetting or vortexing must be avoided, as high shear stress can induce peptide aggregation or tertiary structural denaturation. For detailed laboratory preparation guidelines, consult our comprehensive guide on reconstitution protocols.
Maintaining rigorous quality assurance requires non-negotiable verification protocols for every batch of research peptides. PX1 Research enforces a strict analytical testing regimen for every lot of Thymosin Alpha 1 before release for institutional distribution.
Analytical RP-HPLC utilizes a hydrophobic stationary phase and an acetonitrile/water gradient containing 0.1% trifluoroacetic acid (TFA) to resolve target peptides from potential synthetic impurities, ensuring total chemical purity consistently meets or exceeds 98%. Concurrently, electrospray mass spectrometry confirms the precise molecular weight without extraneous ion peaks. Finally, quantitative LAL chromogenic assays confirm endotoxin levels strictly adhere to sub-0.01 EU/μg limits, making the compound safe for sensitive primary cell cultures and in vivo animal models. Detailed testing methodology can be reviewed in our central peptide research hub.
Lyophilized Thymosin Alpha 1 is highly stable when stored under appropriate thermodynamic conditions. For long-term preservation exceeding three months, lyophilized vials must be stored in a sub-zero freezer at -20°C or -80°C, protected from ambient light and atmospheric moisture.
Once reconstituted into aqueous solution, the peptide's shelf life decreases due to hydrolysis and potential aggregation pathways. Reconstituted aliquots should be stored at 2°C to 8°C for short-term experimentation (up to 7 days) or flash-frozen at -80°C in single-use working aliquots to prevent damage from repeated freeze-thaw cycles. Detailed degradation profiles are monitored continuously through our mass spectrometry analysis verification protocols.
PX1 Research supports university laboratories, contract research organizations (CROs), and biotechnology firms requiring consistent bulk quantities of reference peptides for multi-phase study designs. Standardized lot sizes eliminate variable inter-assay baseline noise across longitudinal preclinical research projects.
Qualified institutional buyers can establish a dedicated bulk laboratory account to access custom lot reservations, automated reordering schedules, and customized volume allocations. Orders placed before 12:00 PM PST ship same-day from our dual fulfillment centers in California and Arizona, guaranteeing rapid delivery for time-sensitive laboratory schedules.
Where can I find verified thymosin alpha 1 for sale for research applications?
Verified, high-purity Thymosin Alpha 1 for sale can be sourced directly from PX1 Research. Every lot is domestically synthesized in USA-based, GMP-compliant facilities and thoroughly tested with ISO 17025 third-party COAs including RP-HPLC, MS, and endotoxin analysis.
What purity level is required when sourcing Thymosin Alpha 1 for laboratory experiments?
In vitro and preclinical animal assays require a chemical purity of ≥98% as measured by RP-HPLC. Lower purity levels risk introducing truncated synthetic side products that can confound immunological assays and alter binding kinetics.
Is Thymosin Alpha 1 available for human clinical administration?
No. Thymosin Alpha 1 supplied by PX1 Research is strictly designated for laboratory research use only. It is not for human or animal clinical use, medical administration, diagnosis, or therapeutic applications.
How is Thymosin Alpha 1 identity and purity verified on a per-lot basis?
Every lot undergoes reverse-phase high-performance liquid chromatography (RP-HPLC) to measure chemical purity and electrospray ionization mass spectrometry (ESI-MS) to verify molecular mass and sequence identity, accompanied by an independent ISO 17025 COA.
What are the standard endotoxin thresholds for Thymosin Alpha 1 research vials?
To ensure safety in cell culture and animal models, PX1 Research enforces a strict bacterial endotoxin limit of less than 0.01 EU/μg, verified via quantitative Limulus Amebocyte Lysate (LAL) testing.
How should research-grade Thymosin Alpha 1 be reconstituted in a laboratory environment?
Aseptically reconstitute the lyophilized powder using sterile bacteriostatic water or PBS (pH 7.4). Direct the diluent down the glass vial wall and swirl gently without vortexing or vigorous agitation to prevent structural denaturation.
What are the recommended storage temperatures for lyophilized Thymosin Alpha 1?
Unopened lyophilized vials should be stored at -20°C or -80°C for long-term stability. Reconstituted liquid aliquots should be kept at 2°C to 8°C for up to 7 days or frozen at -80°C for extended use.
How does Thymosin Alpha 1 differ structurally from Thymosin Beta-4?
Thymosin Alpha 1 is a 28-amino acid acidic peptide derived from Thymosin Fraction 5 that signals through TLR pathways. Thymosin Beta-4 is a 43-amino acid peptide that functions as a main actin-monomer sequestering protein involved in cell motility.
Does PX1 Research offer same-day shipping on laboratory peptide orders?
Yes. Orders placed Monday through Friday prior to 12:00 PM PST are processed and shipped same-day from our domestic distribution facilities located in California and Arizona.
Can qualified academic or enterprise laboratories set up a wholesale account for Thymosin Alpha 1?
Yes. Principal investigators, institutional purchasing agents, and corporate CROs can apply for wholesale accounts to access volume pricing, reserved single-lot inventory, and scheduled shipments.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.